Class II recall: OurPharma LLC: fentaNYL Citrate, 1,000 mcg/100 mL (10mcg/mL) Injection solution in 100 mL, 0.9%
OurPharma LLC has issued a Class II recall for fentaNYL Citrate 1,000 mcg/100 mL (10 mcg/mL) Injection in 100 mL 0.9% NaCl bags, NDC 73013-1013-01. The recall was initiated after a complaint reported a discrepancy between the IV bag expiration dates (07/31/2026 and 11/30/2026) and the product expiration date (12/09/2026).
Most relevant for: Clinicians and pharmacy staff managing inpatient or outpatient administration of injectable fentaNYL from this specific lot and NDC.
Read the original at FDA Drug Enforcement ReportsSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More internal medicine updates
- Long-acting injectable noninferior to oral HIV therapy in adherence trialOct 15, 2026
- Ponatinib-Blinatumomab Beats Imatinib-Chemotherapy in Ph-Positive ALL TrialOct 15, 2026
- Isoflurane sedation does not lower mortality in hypoxemic respiratory failureOct 14, 2026
- Trial finds higher mortality with intermittent vs continuous renal-replacement therapyOct 14, 2026
- No Overall Rise in Birth Defects With Early Benzodiazepine UseOct 13, 2026